128 related articles for article (PubMed ID: 36811845)
21. Does endometrial morular metaplasia represent odontogenic differentiation?
Travaglino A; Raffone A; Russo D; Guadagno E; Pignatiello S; Moretta P; Zullo F; Del Basso De Caro M; Insabato L; Mascolo M
Virchows Arch; 2021 Sep; 479(3):607-616. PubMed ID: 33666744
[TBL] [Abstract][Full Text] [Related]
22. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
Liao YM; Song Y; Li YK; Du JH; Zhou Y
Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
[TBL] [Abstract][Full Text] [Related]
23. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
24. Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.
Palacios J; Catasús L; Moreno-Bueno G; Matias-Guiu X; Prat J; Gamallo C
Virchows Arch; 2001 May; 438(5):464-9. PubMed ID: 11407474
[TBL] [Abstract][Full Text] [Related]
25. Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia.
Xu J; Weisman PS
Int J Gynecol Pathol; 2024 May; 43(3):302-307. PubMed ID: 37922945
[TBL] [Abstract][Full Text] [Related]
26. Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy.
Wright MF; Fitzlaff S; Wyeth A; Zaragoza-Watkins M; Podoll MB; Quick CM; Watkins JC
Int J Gynecol Pathol; 2021 May; 40(3):240-247. PubMed ID: 32897964
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Pitfalls Related to Morular Metaplasia in Endometrioid Carcinoma: An Underestimated Issue.
Travaglino A; Raffone A; Gencarelli A; Saracinelli S; Zullo F; Insabato L
Pathobiology; 2021; 88(3):261-266. PubMed ID: 33887731
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carcinoma.
Costigan DC; Dong F; Nucci MR; Howitt BE
Int J Gynecol Pathol; 2020 Mar; 39(2):119-127. PubMed ID: 30702464
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon.
Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A
Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830
[TBL] [Abstract][Full Text] [Related]
30. Incidental diagnosis of atypical polypoid adenomyoma in a young infertile woman.
Dinas K; Daniilidis A; Drizis E; Zaraboukas T; Tzafettas J
Eur J Gynaecol Oncol; 2009; 30(6):701-3. PubMed ID: 20099510
[TBL] [Abstract][Full Text] [Related]
31. Hysteroscopic transcervical resection is useful to diagnose myometrial invasion in atypical polypoid adenomyoma coexisting with atypical endometrial hyperplasia or endometrial cancer with suspicious myometrial invasion.
Yamagami W; Susumu N; Ninomiya T; Nakadaira N; Iwasa N; Kuwahata M; Nomura H; Kataoka F; Banno K; Aoki D
J Obstet Gynaecol Res; 2015 May; 41(5):768-75. PubMed ID: 25491392
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathology of atypical polypoid adenomyoma of the uterus.
Ota S; Catasus L; Matias-Guiu X; Bussaglia E; Lagarda H; Pons C; Muñoz J; Kamura T; Prat J
Hum Pathol; 2003 Aug; 34(8):784-8. PubMed ID: 14506639
[TBL] [Abstract][Full Text] [Related]
33. β-Catenin mutations in recurrent FIGO IA grade I endometrioid endometrial cancers.
Myers A; Barry WT; Hirsch MS; Matulonis U; Lee L
Gynecol Oncol; 2014 Aug; 134(2):426-7. PubMed ID: 24952365
[No Abstract] [Full Text] [Related]
34. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
35. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
[TBL] [Abstract][Full Text] [Related]
36. Endometrioid adenocarcinoma in an extrauterine adenomyoma.
Ulm MA; Robins DB; Thorpe EM; Reed ME
Obstet Gynecol; 2014 Aug; 124(2 Pt 2 Suppl 1):445-448. PubMed ID: 25004322
[TBL] [Abstract][Full Text] [Related]
37. SATB2 is Consistently Expressed in Squamous Morules Associated With Endometrioid Proliferative Lesions and in the Stroma of Atypical Polypoid Adenomyoma.
McCluggage WG; Van de Vijver K
Int J Gynecol Pathol; 2019 Sep; 38(5):397-403. PubMed ID: 30085940
[TBL] [Abstract][Full Text] [Related]
38. Surgical treatment of a rare case of atypical polypoid adenomyoma of the uterus in a menopausal patient: a case report.
Thanasa EI; Thanasa AI; Paraoulakis IE; Kamaretsos EK; Grapsidi VA; Kontogeorgis GP; Gerokostas EA; Chasiotis AN; Kontochristos VC; Thanasas IK
Pan Afr Med J; 2023; 44():118. PubMed ID: 37275297
[TBL] [Abstract][Full Text] [Related]
39. Endometrioid carcinoma of the endometrium: pathologic and molecular features.
Azueta A; Gatius S; Matias-Guiu X
Semin Diagn Pathol; 2010 Nov; 27(4):226-40. PubMed ID: 21309258
[TBL] [Abstract][Full Text] [Related]
40. Mismatch repair protein deficient endometrioid adenocarcinomas, metastasizing to adrenal gland and lymph nodes: Unusual cases with diagnostic implications.
Rekhi B
Indian J Pathol Microbiol; 2015; 58(4):491-5. PubMed ID: 26549074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
